Alumis, a clinical-stage biopharmaceutical company, has announced two phase 3 trials of its TYK2 inhibitor envudeucitinib met their co-primary endpoints in adults with moderate to severe plaque ...
GSK’s potential “functional cure” for hepatitis B drug has proven its worth in a pair of hotly anticipated phase 3 studies, ...
Hutchmed has continued to test sovleplenib in wAIHA in parallel, culminating in the delivery of data from a Chinese phase 3 ...
InvestorsHub on MSN
Zenas BioPharma shares slide despite positive phase 3 data for Obexelimab
Zenas BioPharma (NASDAQ:ZBIO) shares plunged about 50% after the company released results from its Phase 3 INDIGO study ...
TipRanks on MSN
Alumis unveils positive phase 3 data for psoriasis drug
Alumis Inc. ( ($ALMS) ) just unveiled an announcement. On January 6, 2026, Alumis reported positive topline Phase 3 results from its ONWARD1 and ...
Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The study, Step-Up HS, will evaluate Rinvoq ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Use of alternative endpoints in phase 3 oncology trials ...
The U.S. Space Force has selected SpaceX and United Launch Alliance to perform the first seven launches under the National Security Space Launch Program, or NSSL, Phase 3 Lane 2 contracts, Breaking ...
Having played a bit of football in my day, I often relate business concepts to sports. Regardless of whether or not you’re a sports fan, a sports metaphor can help take a complicated and cumbersome ...
Johannesburg residents have been warned to brace for more water outages as Rand Water and Joburg Water begin the third leg of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback